Testing an imaging scan to find gastrointestinal cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study checks how well the LUM Imaging System can detect cancers of the esophagus, colon, or pancreas during the time you are preparing for surgery. It’s mainly meant to see if the scan works safely and clearly for doctors to find cancer areas.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of esophageal, colorectal, or pancreatic adenocarcinoma (or certain related abnormal growths) from a biopsy or cytology, and you are scheduled for surgery (including some endoscopy-based removals).
- You must be 18 years or older and able to follow study instructions.
- You must be medically healthy enough for surgery or an endoscopic procedure and meet blood-test targets (white blood cells, neutrophils, and platelets).
- You must have heart rhythm (QTc) within limits and your blood pressure must not be dangerously high.
- If you can become pregnant, you must use reliable birth control during the study and for 60 days after the imaging medicine is given.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new imaging procedure called LINFU® that may help doctors better detect pancreatic cancer. You may join if you have symptoms or an abnormal scan that suggests pancreatic cancer, and you're scheduled for a biopsy.
This trial tests a new imaging agent, LNTH-2403, to see if it can help visualize tumors in people with certain advanced cancers that have not responded to standard treatments. It may help doctors decide on future treatment options.
This trial uses advanced imaging tests (spectral CT, multimodal MRI, and FAPI PET-CT) before surgery to find if esophageal cancer has spread to lymph nodes. The goal is to improve how doctors predict and diagnose lymph node metastasis using these scans, along with pathology and AI analysis.
This study looks at how CT scans (detailed X-ray pictures) help diagnose pancreatic cancer or hepatobiliary (liver/bile duct) cancers. It may help your care team better decide what’s going on and plan next treatments.
This trial tests a drug called pafolacianine (CYTALUX) that makes cancer cells glow during surgery. It may help doctors see and remove more cancer from the stomach, esophagus, or appendix. You take the drug before surgery, and a special camera shows the glowing cancer.
This trial tests a new imaging agent, 64Cu-LNTH-1363S, to see if it can find certain sarcomas and gastrointestinal cancers. The goal is to help doctors better see where your cancer is and plan the best treatment. You may be eligible if you have a sarcoma or a GI cancer and are willing to have a tumor tissue sample taken.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.